No Data
No Data
Express News | CervoMed Inc: Believes to Fund Its Operating Expenses and Capital Expenditure Requirements Through 2025.
Express News | CervoMed Q2 2024 EPS $(0.27) Beats $(0.42) Estimate, Sales $3.29M Beat $2.08M Estimate
Earnings Flash (CRVO) CERVOMED Posts Q2 Revenue $3.3M
CervoMed 2Q Loss/Shr 27c >CRVO
CervoMed 2Q Research and Development Expenses $3.8M >CRVO
Express News | CervoMed Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
No Data